Baxa Corporation Signs Agreement to Market SMARTPAK® Sterile Bulk Bag for Prescription Compounding

Baxa Corporation, Denver-based provider of systems for automated compounding of sterile medications, announces a co-marketing agreement with Samson Medical Technologies LLC for the promotion of the SmartPak Bags. SmartPak provides a closed system for sterile compounding that complements the Baxa Rapid-Fill™ Automated Syringe Filling System and Repeater™ Pump for fast and accurate production of sterile IV syringes.

Denver, CO, December 05, 2005 --(PR.com)-- Baxa Corporation, the leading manufacturer of equipment for automating the sterile filling of IV and other medication syringes, bags and devices, has signed a co-marketing agreement with Samson Medical Technologies LLC for their SmartPak Sterile Bulk Bag for Prescription Compounding. Under the Agreement, Baxa representatives will promote the closed system for sterile compounding provided by the SmartPak Bags, in conjunction with the Baxa Rapid-Fill™ Automated Syringe Filler (ASF) and the Repeater™ Pharmacy Pump.

SmartPak is a patented packaging system designed for cost effective and efficient prescription IV drug compounding. The easy-to-use system provides an alternative to reconstituting multiple small-volume drug vials, then withdrawing individual doses or pooling larger volumes for automated syringe filling. As such, it reduces the risk of contaminated end product by minimizing manipulations. Provided in a plastic bag, SmartPak eliminates glass breakage and contamination that can occur with glass vial packaging.

“SmartPak was designed to help hospital and alternate site pharmacies meet the challenges of providing compounded intravenous medications in a safe, timely and cost-effective way to patients,” says Marvin Samson, Founder and CEO of Samson Medical Technologies. He continues, “Using the SmartPak Bags with the Baxa automated syringe filler and Repeater Pump will make it easier for pharmacists to comply with best practice for sterile compounding.”

Baxa Corporation focuses on providing technology to health-system pharmacies that improves patient safety, reduces the risk of medication errors and facilitates compliance to USP, JCAHO and other regulatory requirements. Its Rapid-Fill ASF automates the process of filling, capping and labeling of sterile IV syringes from a bulk reservoir, making it the ideal vehicle for SmartPak drug delivery.

Baxa Corporation and Samson Medical Technologies will be demonstrating their complementary technologies at the American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting held this week in Las Vegas, Nevada. Participants can visit Baxa and Samson at booths 2221 and 1722, respectively.

About Baxa Corporation 

Celebrating 30 years of business in 2005, Baxa Corporation is a Denver-based manufacturer of medical devices and systems for preparing, handling, packaging, and administering liquid medications. The company manufactures and markets a wide range of healthcare products for use in hospitals, critical care units and alternate-site pharmacies. Privately held, Baxa Corporation has offices and subsidiaries in Canada, the United Kingdom and Denmark; and distribution partners worldwide. Further information is available at http://www.baxa.com.

About Samson Medical Technologies 

Samson Medical Technologies, LLC, a privately-held, limited liability company, was founded in 1999 by Marvin Samson to provide hospital and alternate site pharmacies with injectable drug delivery systems and programs designed to meet their unique needs. Samson Medical Technologies also creates customized programs to assist pharmacists with sterile product compounding. Its services include design of cleanrooms, equipment design and selection, on-site and off-site training, preparation of standard operating procedures, and procurement of bulk drugs and/or disposables. Further information is available at http://www.samsonmt.com.

### 

Contacts: 

Marian Robinson, Vice President, Marketing
Baxa Corporation: 800.567.2292 ext. 2157 or 303.617.2157
Email: marian.robinson@baxa.com

Maggie Chamberlin Holben, APR
Absolutely Public Relations: 303.984.9801 or 303.669.3558
Email: maggie@absolutelypr.com
Contact
Baxa Corporation
Maggie Chamberlin Holben, APR
303.984.9801 or 303.669.3558
http://www.baxa.com
ContactContact
Categories